Voriconazole (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Voriconazole drug offered from Mylan Pharmaceuticals Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | voriconazole |
| SUBSTANCE NAME: | VORICONAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER, FOR SUSPENSION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-09-25 |
| END MARKETING DATE: | 2018-10-31 |
Voriconazole HUMAN PRESCRIPTION DRUG Details:
| Item Description | Voriconazole from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/mL) |
| START MARKETING DATE: | 2013-09-25 |
| END MARKETING DATE: | 2018-10-31 |
| PRODUCT ID: | 0378-6270_a657abcb-00c2-4bea-8822-d165c6bd0871 |
| PRODUCT NDC: | 0378-6270 |
| APPLICATION NUMBER: | ANDA202361 |
Other VORICONAZOLE Pharmaceutical Manufacturers / Labelers:
